Zhang Dafang, Vice Chairman of the Provincial Committee of the Chinese People's Political Consultative Conference (CPPCC), led a team to visit Zhongnan Yuanpin Stem Cell Science and Technology Park for research!
On August 26, Zhang Dafang, member of the Standing Committee of the National Committee of the Chinese People's Political Consultative Conference (CPPCC) and vice chairman of the Hunan Provincial Committee of the CPPCC, led a research group of the Provincial Committee of the Jiu San Society to visit Zhongnan Genpine Stem Cell Science and Technology Park, to gain a deeper understanding of the development of the biomedical industry.
▲ The research group visited the park
As a leading hardware facility and industrialization platform for stem cells and regenerative medicine in China, Zhongnan Yuanpin Stem Cell Science and Technology Park is the first stem cell industry chain science and technology park in China, which covers the “Hunan Provincial Cell and Tissue Bank” with a storage capacity of more than 5 million copies, “Hunan Provincial Cell Preparation Center”, “Hunan Provincial Cell Factory” and “Hunan Provincial Cell Preparation Center”, all of which are located in the park. Preparation Center”, ‘Stem Cell and Regenerative Medicine Research Institute’, ‘Stem Cell and Regenerative Medicine Transformation Center’, immersive ‘Life Science Experience’ and other core modules. The research group visited the core modules of the park.
▲ The research group visited the park
Accompanied by Prof. Xue Zhigang, Chief Technology Officer of Genpine Biotechnology, the research group visited Hunan Cell Tissue Bank, Hunan Cell Preparation Center, Quality Control Center and R&D Center, to get a comprehensive understanding of Genpine Biotechnology's infrastructure in the stem cell industry, production and preparation technology, scientific research capabilities and other aspects.
▲ In-depth discussion between the two sides
Afterwards, the two sides had an in-depth discussion. Chairman Hu Bo welcomed the visit of the research group, and Prof. Xue Zhigang, Chief Technology Officer and member of the Jiu San Society, introduced the company's regenerative medicine digital platform system and the construction of a new ecosystem of regenerative medicine to the research group.
Source Bio is seizing the opportunity of the fusion of biotechnology and information technology to build a regenerative medicine digital platform system covering cell storage, cell production, cell research and development, pilot platform, regenerative medicine transformation and data center, to further enhance the company's core competitiveness and to better serve the cause of human life and health.
▲In-depth discussion between the two sides
Zhang Dafang, member of the Standing Committee of the National Committee of the Chinese People's Political Consultative Conference (CPPCC), vice chairman of the Hunan Provincial Committee of the CPPCC, and member of the Standing Committee of the Central Committee of the Jiusan Society, fully affirmed the exploration of the regenerative medicine industrialization of Yuanpin Biologicals and encouraged the company to continue to focus on cutting-edge science and technology and to form a sustainable innovation capability. The Jiusan Society will put forward practical suggestions and form high-quality recommendations to contribute wisdom and strength to the realization of scientific and technological self-reliance and self-improvement.
▲Mr. Hu Bo, Chairman of the Board of Directors of Yuanpin Bio
Under the new development pattern of “Healthy China”, the biomedical industry, as a livelihood industry and strategic industry, is ushering in a new round of historical development opportunities. Yuanpin Bio will accelerate the industrialization of scientific research results, promote the high-end and high-quality development of the biopharmaceutical industry, and make greater contributions to the full implementation of the “three high, four new” strategic positioning and mission.
